Is CVE-2023-38956 actively exploited?

CVE-2023-38956 has no public evidence of in-the-wild exploitation as of 2024-11-21.

What is the CVSS score for CVE-2023-38956?

CVE-2023-38956 has a CVSS score of 7.5 (HIGH severity). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.

How do I patch CVE-2023-38956?

Patch guidance is available from zkteco security advisories. CVEDatabase generates AI-assisted remediation guidance on demand for CVE-2023-38956.

Which products are affected by CVE-2023-38956?

1 product: zkteco bioaccess ivs.

Fix CVE-2023-38956 - HIGH zkteco bioaccess ivs

Description

A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.

CVSS Metrics

Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Attack Vector: network
Complexity: low
Privileges: none
User Action: none
Scope: unchanged
Confidentiality: high
Integrity: none
Availability: none
Weaknesses: CWE-22 · Path Traversal

Metadata

Primary Vendor: ZKTECO
Published: 8/3/2023
Last Modified: 11/21/2024
Source: NIST NVD
Note: Verify all details with official vendor sources before applying patches.

CVE-2023-38956

Description

CVSS Metrics

Metadata

Affected Products

Remediation Guidance

Executive Summary